Commonwealth Biotechnologies, Inc. Provides Market Update on Contemplated Acquisition of GL Biochem (Shanghai) Ltd

Published: Jun 11, 2009

RICHMOND, Va.--(BUSINESS WIRE)--Commonwealth Biotechnologies, Inc. (“CBI”) (NASDAQ Capital Market:CBTE) is pleased to provide the following market update reporting on its recently executed term sheet to acquire all of the outstanding shares of GL Biochem (Shanghai) Ltd (“GL Biochem”).

Back to news